A comprehensive view of Licensing / Royalty. This page highlights a small sample of our full coverage.
For real-time access, please log in to your Health Care Sector Market Intelligence Service.
Recent Articles
sample of recent headlines, press releases and get more..
Samsung Bioepis settles patent litigation with J&J, paving way for US sales of plaque psoriasis treatment SB17 from February 22, 2025, upon FDA approval; Sandoz to handle commercialization
Published:
December 01, 2023
by PharmaShots
|
Elevai Labs enters licensing agreement with Yuva Biosciences to potentially develop topical skin-care formulations that combine mitochondrial biology with Elevai’s human umbilical mesenchymal stem cell derived exosomes
Published:
November 29, 2023
by GlobeNewswire
|
AstraZeneca enters into US$419.0M licensing agreement with Yousen Jianheng for the development and commercialization of cancer drug UA022; the early-stage small molecule drug candidate targets KRASG12D mutation
Published:
November 22, 2023
by Marketline - Deals
|
HeartSciences announces closing of license agreements with the Icahn School of Medicine at Mount Sinai to develop and commercialize AI cardiovascular algorithms
Published:
November 20, 2023
by GlobeNewswire
|
Indian Oil to license LyondellBasell’s Hostalen ‘Advanced Cascade Process’ technology for a new 200 kiloton/year HDPE plant that will be built in Panipat, India; plant will commence operations using Avant Z501 and Avant Z509-1 catalysts
Published:
November 17, 2023
by LyondellBasell Industries NV
|
Ask us about our Health Care Sector market view
Trending Chart
Interactive chart with headline count